During the past decade, Forefront Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forefront Research" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Forefront Research" are "Psoriasis" (2 trials), "Alopecia Areata" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Forefront Research" in a lesser frequency.

Most popular intervention types in "Forefront Research" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "LY3471851" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Forefront Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Forefront Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Forefront Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Forefront Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".